1Spatial (LON:SPA) Issues Earnings Results

Key Points

• 1Spatial reported earnings of GBX (0.30) per share for the quarter, with a net margin of 4.54% and a return on equity of 8.11%.
• The company's stock opened at GBX 50.66 and has a market cap of £56.43 million, with a P/E ratio of 50,660.00.
• Analysts maintain a consensus "Buy" rating for 1Spatial, with a target price of GBX 100 and Canaccord Genuity specifically setting a target of GBX 95.

1Spatial (LON:SPA - Get Free Report) released its earnings results on Monday. The company reported GBX (0.30) earnings per share for the quarter, Digital Look Earnings reports. 1Spatial had a net margin of 4.54% and a return on equity of 8.11%.

1Spatial Stock Performance

Shares of SPA stock opened at GBX 50.66 on Tuesday. The stock has a market cap of £56.43 million, a P/E ratio of 50,660.00 and a beta of 0.39. The company has a debt-to-equity ratio of 23.20, a current ratio of 1.14 and a quick ratio of 0.63. The company has a fifty day moving average price of GBX 48.03 and a two-hundred day moving average price of GBX 48.47. 1Spatial has a one year low of GBX 42.94 and a one year high of GBX 72.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group reaffirmed a "buy" rating and issued a GBX 95 target price on shares of 1Spatial in a research report on Monday. Two analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of GBX 100.

About 1Spatial

1Spatial plc is a global leader in providing Location Master Data Management (LMDM) software, solutions and business applications, primarily to the Government, Utilities and Transport sectors via the 1Spatial platform. Our solutions ensure data governance, facilitating the efficient, effective and sustainable operation of customers around the world.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.